Preoperative Cytologic Diagnosis of Warthin-like Variant of Papillary Thyroid Carcinoma

Jisup Kim; Beom Jin Lim; Soon Won Hong; Ju Yeon Pyo

doi:10.4132/jptm.2017.12.26

Articles

Page Path: HOME > J Pathol Transl Med > Volume 52(2); 2018 > Article

Original Article Preoperative Cytologic Diagnosis of Warthin-like Variant of Papillary Thyroid Carcinoma: Jisup Kim, Beom Jin Lim, Soon Won Hong, Ju Yeon Pyo; Journal of Pathology and Translational Medicine 2018;52(2):105-109.
DOI: https://doi.org/10.4132/jptm.2017.12.26
Published online: February 12, 2018

Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

Corresponding Author Ju Yeon Pyo, MD, PhD Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea Tel: +82-2-2019-3540 Fax: +82-2-3463-2103 E-mail: jypyo@yuhs.ac

• Received: October 26, 2017 • Revised: December 15, 2017 • Accepted: December 26, 2017

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next

7,248 Views
150 Download
6 Web of Science
5 Crossref
9 Scopus

Full Article

Download PDF

Abstract
MATERIALS AND METHODS
RESULTS
DISCUSSION
NOTES
REFERENCES

Abstract

Background
Warthin-like variant of papillary thyroid carcinoma (WLV-PTC) is a relatively rare variant of papillary thyroid carcinoma with favorable prognosis. However, preoperative diagnosis using fine-needle aspiration (FNA) specimens is challenging especially with lymphocytic thyroiditis characterized by Hürthle cells and lymphocytic background. To determine a helpful cytological differential point, we compared WLV-PTC FNA findings with conventional papillary thyroid carcinoma with lymphocytic thyroiditis (PTC-LT) and conventional papillary thyroid carcinoma without lymphocytic thyroiditis (PTC) regarding infiltrating inflammatory cells and their distribution. Preoperative diagnosis or potential for WLV-PTC will be helpful for surgeons to decide the scope of operation.
Methods
Of the 8,179 patients treated for papillary thyroid carcinoma between January 2007 and December 2012, 16 patients (0.2%) were pathologically confirmed as WLV-PTC and four cases were available for cytologic review. For comparison, we randomly selected six PTC-LT cases and five PTC cases during the same period. The number of intratumoral and background lymphocytes, histiocytes, neutrophils, and the presence of giant cells were evaluated and compared using conventional smear and ThinPrep preparations.
Results
WLV-PTC showed extensive lymphocytic smear with incorporation of thyroid follicular tumor cell clusters and frequent histiocytes. WLV-PTC was associated with higher intratumoral and background lymphocytes and histiocytes compared with PTC-LT or PTC. The difference was more distinct in liquid-based cytology.
Conclusions
The lymphocytic smear pattern and the number of inflammatory cells of WLV-PTC are different from those of PTC-LT or PTC and will be helpful for the differential diagnosis of WLV-PTC in preoperative FNA.
Keywords: Warthin-like variant; Thyroid cancer, papillary; Hashimoto disease; Biopsy, fine-needle

Warthin-like variant of papillary thyroid carcinoma (WLV-PTC) was first described by Apel et al. [1] in 1995 and named “warthin-like” due to the presence of abundant lymphocytes interspersed in oncocytic follicular epithelial cells resembling the warthin tumor of salivary glands. It is a relatively rare variant of papillary thyroid carcinoma with only 95 cases published in the English literature [2]. This tumor expresses the product of the RET/PTC fusion gene, indicating that it is a variant of papillary thyroid carcinoma [3]. WLV-PTC is a favorable prognostic variant [1,3,4] although ominous behavior has also been reported [5]. The diagnosis of WLV-PTC is relatively simple due to its characteristic morphology. However, preoperative diagnosis using fine-needle aspiration (FNA) samples is challenging because abundant lymphocytes and oncocytic follicular epithelial cells (Hürthle cells) are observed in various lesions associated with lymphocytic thyroiditis. In this study, we compared FNA findings of WLV-PTC, conventional papillary thyroid carcinoma with lymphocytic thyroiditis (PTC-LT), and conventional papillary thyroid carcinoma without lymphocytic thyroiditis (PTC). The characteristics of infiltrating inflammatory cells and their distribution were analyzed to evaluate their usefulness for differential diagnosis. Preoperative differential diagnosis of WLV-PTC will be helpful for surgeons to determine the optimal scope of operation.

Patients and cases: We retrieved 8,179 papillary thyroid carcinoma cases from the Thyroid Cancer Center database, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea between January 2007 and December 2012. Based on the final pathological diagnosis, 16 patients (0.2%) were WLV-PTC including outside consultation cases. We were able to reexamine cytology slides from four of the patients. Six PTC-LT cases and five PTC cases were randomly selected for comparison (Table 1). Each case had been prepared for both conventional smear and liquid-based cytology (ThinPrep, Hologic, Bedford, MA, USA). The Institutional Review Board of Gangnam Severance Hospital (local IRB number: 3-2017-0235) approved this retrospective study and informed consent was waived.
Microscopic evaluation: Three slides (two conventional smears and one ThinPrep) were reviewed in each case. The number of background lymphocytes within tumor clusters as well as the number of histiocytes and neutrophils was counted in 10 high power fields (HPFs, × 200) in each sample slide. Tumor clusters composed of at least five tumor cells were included in this counting. The presence or absence of background giant cells was recorded. In each case, the average number of inflammatory cells per one HPF was recorded and separated into low and high groups for comparison. The cut-off points are shown in Tables 2 and 3.
Statistical analysis: The median number of inflammatory cells per one HPF was compared using the Mann-Whitney U test. Binary group distribution regarding inflammatory cell infiltration was compared using the Fisher's exact test. All statistical analyses were performed using SPSS ver. 23.0 (IBM Corp, Armonk, NY, USA) and p-values less than 0.05 were considered statistically significant.

RESULTS

The baseline clinicopathologic characteristics of each case such as age, gender, preoperative sonographic finding, preoperative FNA diagnosis, surgical pathologic diagnosis, tumor size, and associated thyroiditis are shown in Table 1. The WLV-PTC, PTC-LT, and PTC microscopic findings are shown in Fig. 1. Conventional smear and ThinPrep WLV-PTC samples showed irregular and papillary clusters with oncocytic cytoplasm and many lymphocytes within the tumor clusters and background (Fig. 1B–E) contrary to those of PTC-LT (Fig. 1G–J) and PTC (Fig. 1L–O) showing rare intratumoral and background lymphocytes. In WLV-PTC, the lymphocytic smear pattern was not different between the conventional and ThinPrep preparations.

The median number, range, and group distributions of inflammatory cells in WLV-PTC, PTC-LT, and PTC in conventional smears and in liquid-based smears are summarized in Tables 2 and 3. In conventional smears, WLV-PTC showed a tendency for association with higher numbers of lymphocytes within tumor clusters and in the background compared with PTC-LT or PTC. WLV-PTC was significantly associated with a high number of background lymphocytes compared with PTC (p = .048). In ThinPrep preparations, WLV-PTC also showed a significantly higher median number of lymphocytes within tumor clusters (p = .008), in the background (p = .008), and was significantly associated with higher lymphocytes within tumor clusters (p = .008) and the background (p = .008) compared with PTC. WLV-PTC showed a tendency for association with higher lymphocytes within tumors, in the background, and with higher histiocytes. WLV-PTC showed a significantly higher median number of histiocytes per one HPF (p = .048).

As an incidental finding, PTC-LT showed a neutrophilic smear with a higher median number compared with WLV-PTC or PTC (Tables 2, 3, Fig. 1G–J); however, the result was not statistically significant.

DISCUSSION

WLV-PTC is a rare variant of PTC having characteristic histologic features; therefore, histologic diagnosis of this tumor is usually straightforward. However, preoperative diagnosis using conventional or liquid-based cytology techniques is complicated because several diseases resemble each other based on cytologic features. The first description of WLV-PTC cytologic features was done by Yousef et al. in 1997 [6]. Since then, nuclear features typical of PTC combined with oncocytic cytoplasm and lymphocytic background were considered to be the cytologic features of WLV-PTC. Therefore, every tumor or tumor-like condition having both nuclear pseudoinclusions in follicular cells and lymphocytic background should be included on the list of differential diagnoses. This list includes Hashimoto’s thyroiditis, follicular neoplasm with oncocytic change, oncocytic variant of PTC [7], PTC in the background of Hashimoto’s thyroiditis, and tall cell variant of PTC [8]. Paker et al. [8] said the most important differential point is mixture of lymphocytes and oncocytic follicular cells, tissue fragments, and papillary structures. However, distinguishing these diseases by cytologic examination is not always clear cut. Especially in liquid-based cytology, cell clusters are easily dissolved during preparation, which can confer further diagnostic difficulty [7].

In this study, we selected WLV-PTC, PTC-LT, and conventional PTC cases of which the diagnosis was confirmed by postoperative pathological examination. We compared preoperative cytology slides and investigated whether specific clues other than nuclear feature and lymphocytic background could distinguish these diseases. We focused on the component and amount of background and intratumoral inflammatory cells.

Although limitations of our study include relatively small WLV-PTC sample size due to the rarity of the disease, WLV-PTC was associated with higher lymphocytes and histiocytes within tumor clusters and within the background as well. The difference was more distinct in ThinPrep preparations.

Our investigation implies that analyzing inflammatory components in preoperative cytologic diagnosis could be helpful in the differential diagnosis between WLV-PTC and conventional PTC without lymphocytic thyroiditis. If lymphocytes within tumor clusters are also considered, the preoperative diagnosis of this rare WLV-PTC variant is possible; however, further multiinstitutional studies including a large number of WLV-PTC cases will be needed.

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

Fig. 1.

Microscopic findings of Warthin-like variant of papillary thyroid carcinoma (WLV-PTC), conventional papillary thyroid carcinoma with lymphocytic thyroiditis (PTC-LT), and conventional papillary thyroid carcinoma without lymphocytic thyroiditis (PTC). (A) Histologic findings of WLV-PTC. WLV-PTC is composed of atypical follicular cells with abundant oxyphilic cytoplasm and nuclear grooves (inset) showing papillary structures with abundant lymphoid stroma. (B, C) Conventional smear of WLV-PTC showing irregular papillary clusters and numerous lymphocytes in tumor clusters in the bloody background. (D, E) Inflammatory and multinucleated giant cells are rather evenly distributed and hypercellular relative to the conventional smear. Intratumoral lymphocytes are easily seen. (F) Histologic findings of PTC-LT. (G, H) Conventional PTC-LT smear showing papillary tumor clusters without intratumoral lymphocytes, but some neutrophils seen around the tumor clusters in the lymphocytic background. (I, J) Peritumoral neutrophils seen in the lymphocytic background. (K) Histologic findings of PTC. (L–O) Hypercellular smear showing classic cytologic features of papillary carcinoma without inflammatory cells in background in both the conventional smear (L, M) and in ThinPrep (N, O) preparations.

Table 1.

Baseline clinicopathologic characteristics of each case

Case No.	Age (yr)/Sex	Tumor size (cm)	Sonographic feature	FNA diagnosis^a	Pathologic diagnosis	Associated thyroiditis
1	46/F	1.0	Irregular shaped calcified nodule	VI. PTC	PTC-LT	Present
2	45/F	0.9	Suspicious malignant nodule	VI. PTC	PTC-LT	Present
3	46/F	0.6	Suspicious malignant nodule	V. Suspicious PTC	PTC-LT	Present
4	53/F	0.4	Suspicious lesion	VI. PTC	PTC-LT	Present
5	53/F	0.6	Suspicious nodule	V. Suspicious PTC	PTC-LT	Present
6	62/F	0.4	Taller than wider hypoechoic nodule	VI. PTC	PTC-LT	Present
7	76/F	0.5	Suspicious nodule	VI. PTC	PTC	Absent
8	44/F	0.7	Suspicious malignant nodule	V. Suspicious PTC	PTC	Absent
9	49/F	0.6	Suspicious lesion	VI. PTC	PTC	Absent
10	70/M	1.0	Cancer nodule	VI. PTC	PTC	Absent
11	57/F	0.3	Suspicious lesion	VI. PTC	PTC	Absent
12	33/F	1.4	Suspicious nodule	VI. PTC	WLV-PTC	Present
13	59/F	0.3	Low suspicious nodule	V. Suspicious PTC	WLV-PTC	Absent
14	40/F	0.6	Oval shaped mass with poor enhancement	V. Suspicious PTC	WLV-PTC	Absent
15	48/F	0.4	Suspicious nodule	VI. PTC	WLV-PTC	Present

FNA, fine-needle aspiration; F, female; PTC, conventional papillary thyroid carcinoma without lymphocytic thyroiditis around the tumor; PTC-LT, conventional papillary thyroid carcinoma with lymphocytic thyroiditis around the tumor; M, male; WLV-PTC, Warthin-like variant of papillary thyroid carcinoma.

^aDiagnostic categories according to the Bethesda system for reporting thyroid cytopathology.

Table 2.

Comparison of inflammatory cell components among the papillary thyroid cancer groups in conventional smears

Inflammatory cell component	WLV-PTC (n = 4)	PTC-LT (n = 6)	PTC (n = 5)	WLV-PTC vs PTC-LT p-value	WLV-PTC vs PTC p-value
Lymphocyte
Background	38.00 (1–154)	7.50 (1–41)	14.00 (5–22)	.524^a	.206^a
Low (≤ 30)	1 (25)	5 (83)	5 (100)	.190^b	.048^b
High (> 30)	3 (75)	1 (17)	0
Within tumor	11.50 (0–51)	1.50 (0–3)	0.00 (0–2)	.999^a	.524^a
Low (≤ 10)	2 (50)	6 (100)	5 (100)	.133^b	.167^b
High (> 10)	2 (50)	0	0
Histiocyte	5.00 (1–9)	1.00 (0–2)	1.00 (1–29)	.999^a	.999^a
Low (< 1)	1 (25)	2 (33)	0	.999^b	.444^b
High (≥ 1)	3 (75)	4 (67)	5 (100)
Giant cell
Absent	2 (50)	3 (50)	3 (60)	.999^b	.999^b
Present	2 (50)	3 (50)	2 (40)
Neutrophil	3.50 (0–6)	5.00 (1–22)	4.00 (1–26)	.999^a	.999^a
Low (≤ 10)	4 (100)	4 (67)	4 (80)	.467^b	.999^b
High (> 10)	0	2 (33)	1 (20)

Values are presented as median (range) or number (%).

WLV-PTC, Warthin-like variant of papillary thyroid carcinoma; PTC-LT, conventional papillary thyroid carcinoma with lymphocytic thyroiditis around the tumor; PTC, conventional papillary thyroid carcinoma without lymphocytic thyroiditis around the tumor.

^aMann–Whitney U test;

^bFisher exact test.

Table 3.

Comparison of inflammatory cell components among the papillary thyroid cancer groups in liquid-based cytology (ThinPrep)

	WLV-PTC (n = 4)	PTC-LT (n = 6)	PTC (n = 5)	WLV-PTC vs PTC-LT p-value	WLV-PTC vs PTC p-value
Lymphocyte
Background	38.00 (17–47)	23.50 (6–71)	4.00 (2–8)	.999^a	.008^a
Low (≤ 10)	0	3 (50)	5 (100)	.200^b	.008^b
High (> 10)	4 (100)	3 (50)	0
Within tumor	14.50 (5–22)	3.50 (0–10)	0 (0–0)	.190^a	.008^a
Low (< 1)	0 (0)	2 (33)	5 (100)	.467^b	.008^b
High (≥ 1)	4 (100)	4 (66)	0
Histiocyte	11.00 (8–12)	1.50 (0–13)	1.00 (0–91)	.048^a	.206^a
Low (≤ 10)	1 (25)	5 (83)	4 (80)	.190^b	.206^b
High (> 10)	3 (75)	1 (17)	1 (20)
Giant cell				.400^b	.524^b
Absent	1 (25)	0	3 (60)
Present	3 (75)	6 (100)	2 (40)
Neutrophil	3.00 (1–12)	16.00 (1–47)	2.00 (0–10)	.524^a	.999^a
Low (≤ 10)	3 (75)	3 (50)	5 (100)	.571^b	.444^b
High (> 10)	1 (25)	3 (50)	0

Values are presented as median (range) or number (%).

^aMann–Whitney U test;

^bFisher exact test.

REFERENCES

1. Apel RL, Asa SL, LiVolsi VA. Papillary Hurthle cell carcinoma with lymphocytic stroma: “Warthin-like tumor” of the thyroid. Am J Surg Pathol 1995; 19: 810-4. Article PubMed
2. Jun HH, Kim SM, Hong SW, Lee YS, Chang HS, Park CS. Warthinlike variant of papillary thyroid carcinoma: single institution experience. ANZ J Surg 2016; 86: 492-4. Article PubMed
3. D’Antonio A, De Chiara A, Santoro M, Chiappetta G, Losito NS. Warthin-like tumour of the thyroid gland: RET/PTC expression indicates it is a variant of papillary carcinoma. Histopathology 2000; 36: 493-8. Article PubMed
4. Ludvíková M, Ryška A, Korabecˇná M, Rydlová M, Michal M. Oncocytic papillary carcinoma with lymphoid stroma (Warthin-like tumour) of the thyroid: a distinct entity with favourable prognosis. Histopathology 2001; 39: 17-24. Article PubMed
5. Mai KT, Thomas J, Yazdi HM, Commons AS, Lamba M, Stinson AW. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma. Appl Immunohistochem Mol Morphol 2004; 12: 329-37. Article PubMed
6. Yousef O, Dichard A, Bocklage T. Aspiration cytology features of the warthin tumor-like variant of papillary thyroid carcinoma: a report of two cases. Acta Cytol 1997; 41(4 Suppl):1361-8. Article PubMed
7. Chong Y, Suh S, Kim TJ, Lee EJ. Fine needle aspiration cytology of Warthin-like papillary thyroid carcinoma: a brief case report. Korean J Pathol 2014; 48: 170-3. Article PubMed PMC
8. Paker I, Kokenek TD, Yilmazer D, Seker GE, Alper M. Oncocytic variant of papillary thyroid carcinoma with lymphocytic stroma (Warthin-like variant): report of a case with fine needle aspiration cytology and review of the literature. Cytopathology 2012; 23: 408-10. Article PubMed

Figure & Data

References

Citations

Citations to this article as recorded by

Warthin-like variant of papillary thyroid carcinoma with lymph node metastases: a case report and review of the literature
Andrii Hryshchyshyn, Andrii Bahrii, Pavlina Botsun, Volodymyr Chuba
Journal of Medical Case Reports.2024;[Epub] CrossRef
Warthin-like papillary thyroid carcinoma: a case report and comprehensive review of the literature
Abdel Mouhaymen Missaoui, Fatma Hamza, Wafa Belabed, Manel Mellouli, Mohamed Maaloul, Slim Charfi, Issam Jardak, Tahya Sellami-Boudawara, Nabila Rekik, Mohamed Abid
Frontiers in Endocrinology.2023;[Epub] CrossRef
The Warthin-like variant of papillary thyroid carcinomas: a clinicopathologic analysis report of two cases
Xing Zhao, Yijia Zhang, Pengyu Hao, Mingzhen Zhao, Xingbin Shen
Oncologie.2023; 25(5): 581. CrossRef
Challenges in Cytology Specimens With Hürthle Cells
Eleni Thodou, Sule Canberk, Fernando Schmitt
Frontiers in Endocrinology.2021;[Epub] CrossRef
Warthin-like variant of Papillary thyroid carcinoma—Case report of an uncommon tumour with review of literature
Pradyumna Kumar Sahoo, Rashmi Patnayak, Perwez Alam Khan, Amitabh Jena
International Journal of Surgery Case Reports.2020; 77: 9. CrossRef

PubReader
ePub Link

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Preoperative Cytologic Diagnosis of Warthin-like Variant of Papillary Thyroid Carcinoma

J Pathol Transl Med. 2018;52(2):105-109. Published online February 12, 2018

DOI: https://doi.org/10.4132/jptm.2017.12.26

XML Download

Figure

Related articles

Preoperative Cytologic Diagnosis of Warthin-like Variant of Papillary Thyroid Carcinoma

Fig. 1. Microscopic findings of Warthin-like variant of papillary thyroid carcinoma (WLV-PTC), conventional papillary thyroid carcinoma with lymphocytic thyroiditis (PTC-LT), and conventional papillary thyroid carcinoma without lymphocytic thyroiditis (PTC). (A) Histologic findings of WLV-PTC. WLV-PTC is composed of atypical follicular cells with abundant oxyphilic cytoplasm and nuclear grooves (inset) showing papillary structures with abundant lymphoid stroma. (B, C) Conventional smear of WLV-PTC showing irregular papillary clusters and numerous lymphocytes in tumor clusters in the bloody background. (D, E) Inflammatory and multinucleated giant cells are rather evenly distributed and hypercellular relative to the conventional smear. Intratumoral lymphocytes are easily seen. (F) Histologic findings of PTC-LT. (G, H) Conventional PTC-LT smear showing papillary tumor clusters without intratumoral lymphocytes, but some neutrophils seen around the tumor clusters in the lymphocytic background. (I, J) Peritumoral neutrophils seen in the lymphocytic background. (K) Histologic findings of PTC. (L–O) Hypercellular smear showing classic cytologic features of papillary carcinoma without inflammatory cells in background in both the conventional smear (L, M) and in ThinPrep (N, O) preparations.

Fig. 1.

Preoperative Cytologic Diagnosis of Warthin-like Variant of Papillary Thyroid Carcinoma

Case No.	Age (yr)/Sex	Tumor size (cm)	Sonographic feature	FNA diagnosis^a	Pathologic diagnosis	Associated thyroiditis
1	46/F	1.0	Irregular shaped calcified nodule	VI. PTC	PTC-LT	Present
2	45/F	0.9	Suspicious malignant nodule	VI. PTC	PTC-LT	Present
3	46/F	0.6	Suspicious malignant nodule	V. Suspicious PTC	PTC-LT	Present
4	53/F	0.4	Suspicious lesion	VI. PTC	PTC-LT	Present
5	53/F	0.6	Suspicious nodule	V. Suspicious PTC	PTC-LT	Present
6	62/F	0.4	Taller than wider hypoechoic nodule	VI. PTC	PTC-LT	Present
7	76/F	0.5	Suspicious nodule	VI. PTC	PTC	Absent
8	44/F	0.7	Suspicious malignant nodule	V. Suspicious PTC	PTC	Absent
9	49/F	0.6	Suspicious lesion	VI. PTC	PTC	Absent
10	70/M	1.0	Cancer nodule	VI. PTC	PTC	Absent
11	57/F	0.3	Suspicious lesion	VI. PTC	PTC	Absent
12	33/F	1.4	Suspicious nodule	VI. PTC	WLV-PTC	Present
13	59/F	0.3	Low suspicious nodule	V. Suspicious PTC	WLV-PTC	Absent
14	40/F	0.6	Oval shaped mass with poor enhancement	V. Suspicious PTC	WLV-PTC	Absent
15	48/F	0.4	Suspicious nodule	VI. PTC	WLV-PTC	Present

Inflammatory cell component	WLV-PTC (n = 4)	PTC-LT (n = 6)	PTC (n = 5)	WLV-PTC vs PTC-LT p-value	WLV-PTC vs PTC p-value
Lymphocyte
Background	38.00 (1–154)	7.50 (1–41)	14.00 (5–22)	.524^a	.206^a
Low (≤ 30)	1 (25)	5 (83)	5 (100)	.190^b	.048^b
High (> 30)	3 (75)	1 (17)	0
Within tumor	11.50 (0–51)	1.50 (0–3)	0.00 (0–2)	.999^a	.524^a
Low (≤ 10)	2 (50)	6 (100)	5 (100)	.133^b	.167^b
High (> 10)	2 (50)	0	0
Histiocyte	5.00 (1–9)	1.00 (0–2)	1.00 (1–29)	.999^a	.999^a
Low (< 1)	1 (25)	2 (33)	0	.999^b	.444^b
High (≥ 1)	3 (75)	4 (67)	5 (100)
Giant cell
Absent	2 (50)	3 (50)	3 (60)	.999^b	.999^b
Present	2 (50)	3 (50)	2 (40)
Neutrophil	3.50 (0–6)	5.00 (1–22)	4.00 (1–26)	.999^a	.999^a
Low (≤ 10)	4 (100)	4 (67)	4 (80)	.467^b	.999^b
High (> 10)	0	2 (33)	1 (20)

	WLV-PTC (n = 4)	PTC-LT (n = 6)	PTC (n = 5)	WLV-PTC vs PTC-LT p-value	WLV-PTC vs PTC p-value
Lymphocyte
Background	38.00 (17–47)	23.50 (6–71)	4.00 (2–8)	.999^a	.008^a
Low (≤ 10)	0	3 (50)	5 (100)	.200^b	.008^b
High (> 10)	4 (100)	3 (50)	0
Within tumor	14.50 (5–22)	3.50 (0–10)	0 (0–0)	.190^a	.008^a
Low (< 1)	0 (0)	2 (33)	5 (100)	.467^b	.008^b
High (≥ 1)	4 (100)	4 (66)	0
Histiocyte	11.00 (8–12)	1.50 (0–13)	1.00 (0–91)	.048^a	.206^a
Low (≤ 10)	1 (25)	5 (83)	4 (80)	.190^b	.206^b
High (> 10)	3 (75)	1 (17)	1 (20)
Giant cell				.400^b	.524^b
Absent	1 (25)	0	3 (60)
Present	3 (75)	6 (100)	2 (40)
Neutrophil	3.00 (1–12)	16.00 (1–47)	2.00 (0–10)	.524^a	.999^a
Low (≤ 10)	3 (75)	3 (50)	5 (100)	.571^b	.444^b
High (> 10)	1 (25)	3 (50)	0

Table 1. Baseline clinicopathologic characteristics of each case

Diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.

Table 2. Comparison of inflammatory cell components among the papillary thyroid cancer groups in conventional smears

Values are presented as median (range) or number (%).

Mann–Whitney U test;

Fisher exact test.

Table 3. Comparison of inflammatory cell components among the papillary thyroid cancer groups in liquid-based cytology (ThinPrep)

Values are presented as median (range) or number (%).

Mann–Whitney U test;

Fisher exact test.

Articles

Abstract

MATERIALS AND METHODS

RESULTS

DISCUSSION

REFERENCES

Figure & Data

References

Citations

Fig. 1.

Table 1.

Table 2.

Table 3.